RevCycleAIBanjo Health profile →
Company Deep Dive · Prior Authorization

Banjo Health: AI-assisted prior authorization for the payer side of the workflow

Banjo Health is building prior authorization infrastructure for health plans and PBMs—not a provider-side letter generator. Its product turns incoming cases and dense clinical policies into structured review workflows while keeping final clinical decisions with human reviewers.
RevCycleAI · Updated August 19, 2026 · Independent market analysis

RevCycleAI take

Banjo sits in an important but less visible part of the prior-auth stack: the payer/PBM operating layer. The value proposition is straightforward—ingest cases from mixed channels, extract the relevant clinical information, map the case to criteria, recommend a disposition, and give reviewers a cleaner workflow with a complete audit history.

The strategic question is not whether AI can accelerate a reviewer. It is whether Banjo can become durable infrastructure as CMS interoperability rules, electronic prior authorization, clinical policy complexity and state-level requirements push payers toward more standardized decision workflows.

What Banjo actually does

Banjo's CARE engine is designed to support medical and pharmacy prior authorization from intake through review and appeal. The company describes an intake-agnostic model that can extract information from faxed or digital requests, create cases, compare data against clinical criteria and recommend actions such as approve, deny or request more information.

  • Medical and pharmacy prior authorization workflow
  • AI-assisted case intake and data extraction
  • Clinical criteria management and decision-tree creation
  • Automated clinical review and recommendation support
  • Appeals workflow
  • Searchable decision history for compliance and audits
  • API-first connectivity into existing payer/PBM systems

Who should care

The clearest buyers are health plans and pharmacy benefit managers with high prior-auth volume, fragmented intake channels and expensive clinical review teams. The product is most relevant where the goal is to increase reviewer throughput without removing clinical governance.

Best fit

Enterprise payers and PBMs with enough case volume to justify workflow redesign, integration work and clinical-policy configuration.

Less obvious fit

Provider organizations looking primarily to create submissions or automate portal chasing. Banjo's center of gravity is the adjudication side, not the provider revenue-cycle side.

What to diligence

  • Automation depth: What percentage of cases become true straight-through processing versus AI-assisted reviewer work?
  • Clinical-policy maintenance: How quickly can criteria updates be operationalized and audited across lines of business?
  • Exception handling: How does the platform perform when medical records are incomplete or policies conflict?
  • Integration burden: What systems are required for intake, member data, claims history and final disposition?
  • Regulatory controls: How are human review, denial rationale and decision traceability handled as regulation evolves?

Competitive frame

Banjo should be compared less with provider-side prior-auth automation and more with payer utilization-management infrastructure, clinical criteria systems and workflow vendors. Its differentiation rests on combining AI-assisted review with human control and an API-first architecture rather than trying to remove clinicians from the decision.